Summary
The changes in the synthesis and utilization of noradrenaline cranial and caudal to an acute section of the rat spinal cord have been used to investigate the importance of nerve impulses for these processes.
-
1.
Cranial to a lesion of the spinal cord, the α-methyltyrosine-induced disappearance of noradrenaline was accelerated by the α-adrenoreceptor blocking agents yohimbine (10 mg/kg), piperoxan (60 mg/kg) and tolazoline (50 mg/kg). In the absence of nerve impulses caudal to a lesion of the spinal cord, this disappearance was decelerated as compared to that cranial to the lesion and it was not influenced by the three α-adrenoreceptor blocking agents.
-
2.
The nialamide-induced accumulation of normetanephrine in the whole brain was increased by phenoxybenzamine (20 mg/kg) and yohimbine whereas it was decreased by the α-adrenoreceptor stimulating agent clonidine (0.1 mg/kg). The effect of clonidine was completely antagonized by yohimbine, but not by phenoxybenzamine, giving further evidence for the view that clonidine and yohimbine have a stronger effect than phenoxybenzamine on the α-adrenoreceptors regulating the release of noradrenaline induced by nerve impulses.
-
3.
The accumulation of Dopa after decarboxylase inhibition cranial to a lesion of the spinal cord was accelerated by yohimbine, piperoxan and tolazoline, but not significantly affected by phenoxybenzamine and haloperidol (10 mg/kg). In the absence of nerve impulses caudal to a lesion of the spinal cord, the Dopa accumulation was decelerated as compared to that cranial to the lesion and it was not influenced by the former three α-adrenoreceptor blocking agents as well as by clonidine.
-
4.
The results show that the synthesis and the utilization of noradrenaline normally, as well as the accelerations of these processes by α-adrenoreceptor blocking agents, are dependent on nerve impulses. The stimulation of the synthesis and utilization of noradrenaline by nerve impulses might be influenced via the activity of the α-adrenoreceptors located either on the nerve terminals or on the cell bodies or on both parts of the noradrenergic neurones. In the absence of nerve impulses, a receptor-mediated feed-back mechanism similar to that described for the synthesis of dopamine does not appear to regulate the synthesis of noradrenaline.
Similar content being viewed by others
References
Agid, Y., Javoy, F., Glowinski, J.: Chemical or electrolytic lesion of the substantia nigra: early effects on neostriatal dopamine metabolism. Brain Res. 74, 41–49 (1974)
Andén, N.-E., Börjesson, B., Magnusson, T.: Normetanephrine accumulation in the spinal cord due to nerve impulse activity. Europ. J. Pharmacol. 4, 349–351 (1968)
Andén, N.-E., Grabowska, M., Strömbom, U.: Different alpha-adrenoreceptors in the central nervous system mediating biochemical and functional effects of clonidine and receptor blocking agents. Naunyn-Schmiedeberg's Arch. Pharmacol. 292, 43–52 (1976)
Andén, N.-E., Bédard, P., Fuxe, K., Ungerstedt, U.: Early and selective increase in brain dopamine levels after axotomy. Experientia (Basel) 28, 300–301 (1972)
Andén, N.-E., Corrodi, H., Fuxe, K., Hökfelt, T.: Increased impulse flow in bulbospinal noradrenaline neurons produced by catecholamine receptor blocking agents. Europ. J. Pharmacol. 2, 59–64 (1967)
Andén, N.-E., Corrodi, H., Fuxe, K., Ungerstedt, U.: Importance of nervous impulse flow for the neuroleptic induced increase in amine turnover in central dopamine neurons. Europ. J. Pharmacol. 15, 193–199 (1971)
Andén, N.-E., Häggendal, J., Magnusson, T., Rosengren, E.: The time course of the disappearance of noradrenaline and 5-hydroxytryptamine in the spinal cord after transection. Acta physiol. scand. 62, 115–118 (1964)
Andén, N.-E., Corrodi, H., Dahlström, A., Fuxe, K., Hökfelt, T.: Effects of tyrosine hydroxylase inhibition on the amine levels of central monoamine neurons. Life Sci. 5, 605–611 (1966)
Andén, N.-E., Corrodi, H., Fuxe, K., Hökfelt, B., Hökfelt, T., Rydin, C., Svensson, T.: Evidence for a central noradrenaline receptor stimulation by clonidine. Life Sci. 9 (I), 513–523 (1970)
Atack, C. V., Magnusson, T.: Individual elution of noradrenaline (together with adrenaline), dopamine, 5-hydroxytryptamine and histamine from a single, strong cation exchange column, by means of mineral acid-organic solvent mixtures. J. Pharm. Pharmacol. 22, 625–627 (1970)
Axelrod, J.: Methylation reactions in the formation and metabolism of catecholamines and other biogenic amines. Pharmacol. Rev. 18, 95–113 (1966)
Besson, M. J., Cheramy, A., Gauchy, C., Glowinski, J.: In vivo continuous estimation of 3H-dopamine synthesis and release in the cat caudate nucleus: effects of α-methyl-p-tyrosine and of transection of the nigro-neostriatal pathway. Naunyn-Schmiedeberg's Arch. Pharmacol. 278, 101–105 (1973)
Carlsson, A.: Discussion. In: Adrenergic mechanisms, J. R. Vane, G. E. W. Wolstenholme and M. O'Connor, eds., pp. 558–559. London: Churchill 1960
Carlsson, A., Lindqvist, M.: A method for the determination of normetanephrine in brain. Acta physiol. scand. 54, 83–86 (1962)
Carlsson, A., Waldeck, B.: A method for the fluorimetric determination of 3-methoxytyramine in tissues and the occurrence of this amine in brain. Scand. J. clin. Lab. Invest. 16, 133–138 (1964)
Carlsson, A., Falck, B., Fuxe, K., Hillarp, N.-Å.: Cellular localization of monoamines in the spinal cord. Acta physiol. scand. 60, 112–119 (1964)
Carlsson, A., Davis, J. N., Kehr, W., Lindqvist, M., Atack, C. V.: Simultaneous measurement of tyrosine and tryptophan hydroxylase activities in brain in vivo using an inhibitor of the aromatic amino acid decarboxylase. Naunyn-Schmiedeberg's Arch. Pharmacol. 275, 153–168 (1972)
Corrodi, H., Hanson, L. C. F.: Central effects of an inhibitor of tyrosine hydroxylation. Psychopharmacologia (Berl.) 10, 116–125 (1966)
Dahlström, A., Fuxe, K.: Evidence for the existence of monoamine neurons in the central nervous system. II. Experimentally induced changes in the intraneuronal amine levels of bulbo-spinal neuron systems. Acta physiol. scand. 64, Suppl. 247, 1–36 (1965)
Häggendal, J.: An improved method for fluorimetric determination of small amounts of adrenaline and noradrenaline in plasma and tissues. Acta physiol. scand. 59, 242–254 (1963)
Kehr, W.: Temporal changes in catecholamine synthesis of rat forebrain structures after axotomy. J. Neural Transmission 35, 307–317 (1974)
Kehr, W., Carlsson, A., Lindqvist, M.: A method for the determination of 3,4-dihydroxyphenylalanine (DOPA) in brain. Naunyn-Schmiedeberg's Arch. Pharmacol. 274, 273–280 (1972a)
Kehr, W., Carlsson, A., Lindqvist, M., Magnusson, T., Atack, C.: Evidence for a receptor-mediated feedback control of striatal tyrosine hydroxylase activity. J. Pharm. Pharmacol. 24, 744–747 (1972b)
Magnusson, T.: Effect of chronic transection on dopamine, noradrenaline and 5-hydroxytryptamine in the rat spinal cord. Naunyn-Schmiedeberg's Arch. Pharmacol. 278, 13–22 (1973)
Spector, S., Sjoerdsma, A., Udenfriend, S.: Blockade of endogenous norepinephrine synthesis by α-methyltyrosine, an inhibitor of tyrosine hydroxylase. J. Pharmacol. exp. Ther. 147, 86–95 (1965)
Stanton, E. S., Smolen, P. M., Nashold B. S., Jr., Dreyer, D. A., Davis, J. N.: Segmental analysis of spinal cord monoamines after thoracic transection in the dog. Brain Res. 89, 93–98 (1975)
Stock, G., Magnusson, T., Andén, N.-E.: Increase in brain dopamine after axotomy or treatment with gammahydroxybutyric acid due to elimination of the nerve impulse flow. Naunyn-Schmiedeberg's Arch. Pharmacol. 278, 347–361 (1973)
Walters, J. R., Roth, R. H.: Dopaminergic neurons: drug-induced antagonism of the increase in tyrosine hydroxylase activity produced by cessation of impulse flow. J. Pharmacol. exp. Ther. 191, 82–91 (1974)
Walters, J. R., Roth, R. H., Aghajanian, G. K.: Dopaminergic neurons: similar biochemical and histochemical effects of γ-hydroxybutyrate and acute lesions of the nigro-neostriatal pathway. J. Pharmacol. exp. Ther. 186, 630–639 (1973)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Grabowska, M., Andén, NE. Noradrenaline synthesis and utilization: Control by nerve impulse flow under normal conditions and after treatment with alpha-adrenoreceptor blocking agents. Naunyn-Schmiedeberg's Arch. Pharmacol. 292, 53–58 (1976). https://doi.org/10.1007/BF00506489
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00506489